Record IMCIVREE Start Forms and 19% Quarterly Revenue Growth Highlight Rhythm Pharmaceuticals’ Q2 2026
Market Chameleon (Tue, 4-Aug 7:42 AM)
Rhythm Pharmaceuticals to Reveal Interim Phase 2 Data on Setmelanotide for Prader-Willi Syndrome—Key Catalysts Ahead
Market Chameleon (Mon, 15-Jun 11:07 AM)
